Back

The transcription factor NF-Y promotes myeloid cell survival and protects from inflammatory vascular disease

Silvestre-Roig, C.; Gonzalez-Granado, J. M.; Gonzalo, P.; Vöcking, L. M.; Chevre, R.; Esteban, V.; Andres Garcia, V.

2026-02-03 immunology
10.64898/2026.01.29.702697 bioRxiv
Show abstract

BackgroundMyeloid cells orchestrate vascular inflammation through transcriptional programs that regulate their maturation, effector function, and survival. While lineage-determining transcription factors establish myeloid identity, understanding of the transcriptional regulation of myeloid behavior in chronic inflammatory contexts remains limited. Nuclear factor-Y (NF-Y) is a trimeric CCAAT-binding transcription factor that regulates cell proliferation and differentiation. Here, we investigate the role of NF-Y in myeloid function and survival during chronic vascular inflammation. MethodsIntegrated single-cell transcriptomics of BM, blood, and atherosclerotic lesions were combined with myeloid-specific NF-YA inactivation to define NF-Y-dependent transcriptional states. Functional consequences were assessed in mice with myeloid-specific Nfya deletion on a hypercholesterolemic Apoe-/- background using models of diet-induced advanced atherosclerosis and endoluminal femoral injury. Myeloid cell recruitment, survival, apoptosis, and proliferation were further examined in models of thioglycolate-induced peritonitis. ResultsNF-Y subunit transcripts were detected across myeloid compartments, with Nfya enriched in proliferative macrophages and immature neutrophils. In mouse atherosclerotic lesions, low Nfya expression was associated with lipid-handling and phagocytic macrophage signatures and a pro-inflammatory neutrophil phenotype. Myeloid Nfya deficiency was further associated with reduced circulating neutrophil counts, increased macrophage and neutrophil apoptosis during acute inflammation, expanded necrotic cores, larger unstable atherosclerotic lesions, and aggravated atherosclerosis and injury-induced neointimal thickening. ConclusionOur data identify NF-Y as a transcriptional safeguard of myeloid cell survival during inflammatory stress, thereby shaping disease progression and outcomes in vascular disease.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 0.1%
23.6%
2
Atherosclerosis
29 papers in training set
Top 0.1%
15.4%
3
Circulation Research
39 papers in training set
Top 0.1%
7.5%
4
Cardiovascular Research
33 papers in training set
Top 0.1%
7.2%
50% of probability mass above
5
Circulation
66 papers in training set
Top 0.7%
5.1%
6
Journal of Clinical Investigation
164 papers in training set
Top 0.9%
3.8%
7
Journal of the American Heart Association
119 papers in training set
Top 2%
3.4%
8
JCI Insight
241 papers in training set
Top 2%
2.5%
9
Arthritis & Rheumatology
33 papers in training set
Top 0.2%
2.0%
10
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.0%
11
Nature Cardiovascular Research
28 papers in training set
Top 0.2%
1.9%
12
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 2%
1.7%
13
Frontiers in Immunology
586 papers in training set
Top 5%
1.4%
14
Journal of Cerebral Blood Flow & Metabolism
43 papers in training set
Top 0.4%
1.3%
15
PLOS ONE
4510 papers in training set
Top 61%
1.2%
16
JACC: Basic to Translational Science
15 papers in training set
Top 0.3%
0.9%
17
Nature Communications
4913 papers in training set
Top 58%
0.9%
18
Science Translational Medicine
111 papers in training set
Top 4%
0.9%
19
Scientific Reports
3102 papers in training set
Top 72%
0.8%
20
Immunology
29 papers in training set
Top 0.9%
0.8%
21
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.8%
22
Cell Reports
1338 papers in training set
Top 35%
0.7%